ZZW-115

产品说明书

Print
Chemical Structure| 801991-87-7 同义名 : -
CAS号 : 801991-87-7
货号 : A1365243
分子式 : C24H31F3N4S
纯度 : 99%
分子量 : 464.59
MDL号 : MFCD34469422
存储条件:

Pure form Inert atmosphere, 2-8°C

In solvent -20°C:3-6个月-80°C:12个月

溶解度 : -
动物实验配方:
生物活性
描述 ZZW-115 is a potent NUPR1 inhibitor with a Kd value of 2.1 μM. ZZW-115 induces tumour cell death through necrosis and apoptosis[1][2].ZZW-115 was effective in killing cancer cells in the concentration range of 0.1-33 μM for 72 h. The IC50 of ZZW-115 ranged from 0.84 μM (ANOR) to 4.93 μM (HN14). ZZW-115 induced necrosis and apoptosis of pancreatic cells, and during its action, it caused a decrease in the production of ATP and induced the overproduction of ROS. LDH release from ZZW-115-treated cells (MiaPaCa-2, 02-063, LIPC, Foie8b and HN14 cells) was significantly higher than that from control cells in a concentration-dependent manner. Similarly, caspase 3/7 activity was higher in ZZW-115-treated cells. These experiments suggest that ZZW-115 also has a pro-apoptotic effect[1].
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

2.15mL

0.43mL

0.22mL

10.76mL

2.15mL

1.08mL

21.52mL

4.30mL

2.15mL

参考文献

[1]Santofimia-Castaño P, et al. Ligand-based design identifies a potent NUPR1 inhibitor exerting anticancer activity via necroptosis. J Clin Invest. 2019;129(6):2500-2513. Published 2019 Mar 28.

[2]Santofimia-Castaño P, et al. Targeting the Stress-Induced Protein NUPR1 to Treat Pancreatic Adenocarcinoma. Cells. 2019;8(11):1453. Published 2019 Nov 17.